[ Price : $8.95]
The Institute for Safe Medicines calls on FDA, the Federal Trade Commission, and the Department of Justice to take enforcement act...[ Price : $8.95]
Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are li...[ Price : $8.95]
FDA cites a U.K.-based clinical research center for failing to promptly report adverse events and for potential falsification of s...[ Price : $8.95]
Vertex Pharmaceuticals says an interim analysis of its Phase 3 RAINIER trial showed its experimental therapy povetacicept signific...[ Price : $8.95]
FDA accepts for review a Capricor Therapeutics BLA resubmission for its experimental cell therapy deramiocel, intended to treat he...[ Price : $8.95]
FDA approves an expanded use of GSKs Wellcovorin (leucovorin calcium) tablets for treating cerebral folate deficiency in adult and...[ Price : $8.95]
Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in p...[ Price : $8.95]
FDA posts an updated draft guidance outlining new and revised recommendations for companies developing biosimilar products.